KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.205
+0.105 (2.56%)
May 26, 2026, 4:00 PM EDT - Market closed
KORU Medical Systems Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, KORU Medical Systems stock has a consensus rating of "Strong Buy" and an average price target of $6.80. The average 1-year stock price forecast is 61.71% higher than the current stock price, while the lowest is $5.00 (+18.91%) and the highest is $8.00 (+90.25%).
Price Target: $6.80 (+61.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KORU Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $6 | Buy | Maintains | $6 | +42.69% | May 7, 2026 |
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +90.25% | May 7, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $5 | Hold | Reiterates | $5 | +18.91% | May 7, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 6, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $7 → $8 | Buy | Reiterates | $7 → $8 | +90.25% | Mar 13, 2026 |
Financial Forecast
Revenue This Year
49.66M
from 41.13M
Increased by 20.75%
Revenue Next Year
58.08M
from 49.66M
Increased by 16.94%
EPS This Year
-0.04
from -0.06
EPS Next Year
0.03
from -0.04
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 51.4M | 61.3M | |
| Avg | 49.7M | 58.1M | |
| Low | 47.1M | 53.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 25.0% | 23.5% | |
| Avg | 20.8% | 16.9% | |
| Low | 14.6% | 7.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.03 | 0.06 | |
| Avg | -0.04 | 0.03 | |
| Low | -0.05 | -0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.